Related Experiment Video
Updated: Jul 25, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent,
Craig McFarlane1, Erin Plummer, Mark Thomas
1AgResearch, Functional Muscle Genomics, East Street, Hamilton, New Zealand.
Abstract:
Myostatin, a transforming growth factor-beta (TGF-beta) super-family member, has been well characterized as a negative regulator of muscle growth and development. Myostatin has been implicated in several forms of muscle wasting including the severe cachexia observed as a result of conditions such as AIDS and liver cirrhosis. Here we show that Myostatin induces cachexia by a mechanism independent of NF-kappaB. Myostatin treatment resulted in a reduction in both myotube number and size in vitro, as well as a loss in body mass in vivo. Furthermore, the expression of the myogenic genes myoD and pax3 was reduced, while NF-kappaB (the p65 subunit) localization and expression remained unchanged. In addition, promoter analysis has confirmed Myostatin inhibition of myoD and pax3. An increase in the expression of genes involved in ubiquitin-mediated proteolysis is observed during many forms of muscle wasting. Hence we analyzed the effect of Myostatin treatment on proteolytic gene expression. The ubiquitin associated genes atrogin-1, MuRF-1, and E214k were upregulated following Myostatin treatment. We analyzed how Myostatin may be signaling to induce cachexia. Myostatin signaling reversed the IGF-1/PI3K/AKT hypertrophy pathway by inhibiting AKT phosphorylation thereby increasing the levels of active FoxO1, allowing for increased expression of atrophy-related genes. Therefore, our results suggest that Myostatin induces cachexia through an NF-kappaB-independent mechanism. Furthermore, increased Myostatin levels appear to antagonize hypertrophy signaling through regulation of the AKT-FoxO1 pathway.
Insights
Myostatin triggers muscle wasting (cachexia) by reducing muscle cell growth and increasing protein breakdown, independent of NF-kappaB signaling. It disrupts the AKT-FoxO1 pathway, promoting atrophy.
Area of Science:
- Muscle biology
- Molecular signaling
- Cellular atrophy
Background:
- Myostatin, a TGF-beta protein, negatively regulates muscle mass.
- Muscle wasting conditions like cachexia are linked to elevated myostatin.
- The precise molecular mechanisms of myostatin-induced cachexia are not fully understood.
Purpose of the Study:
- To investigate the mechanism by which myostatin induces cachexia.
- To determine if myostatin's effect on muscle wasting involves NF-kappaB.
- To elucidate the signaling pathways affected by myostatin.
Main Methods:
- In vitro studies on myotube number and size.
- In vivo body mass measurements.
- Analysis of myogenic gene expression (myoD, pax3) and NF-kappaB.
- Promoter analysis for gene regulation.
- Assessment of ubiquitin-proteolysis gene expression (atrogin-1, MuRF-1, E214k).
- Investigation of the IGF-1/PI3K/AKT/FoxO1 signaling pathway.
Main Results:
- Myostatin treatment reduced myotube size and number in vitro, and body mass in vivo.
- Myostatin decreased myoD and pax3 expression without altering NF-kappaB.
- Expression of atrophy-related genes (atrogin-1, MuRF-1, E214k) increased.
- Myostatin inhibited AKT phosphorylation, activating FoxO1 and upregulating atrophy genes.
- These effects were independent of NF-kappaB.
Conclusions:
- Myostatin induces cachexia via an NF-kappaB-independent pathway.
- Myostatin antagonizes muscle hypertrophy signaling by modulating the AKT-FoxO1 pathway.
- Targeting myostatin or its downstream signaling may offer therapeutic strategies for muscle wasting.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Anaphase Promoting Complex
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

